CO_TASMI 40MG TABLET

CO_TASMI 40MG TABLET is a combination medication that comprises two active ingredients: telmisartan & hydrochlorothiazide. Telmisartan is classified as an angiotensin II receptor blocker (ARB), while hydrochlorothiazide is a thiazide diuretic. This combination is prescribed for the management of hypertension (high blood pressure).

Mechanism of Action:

• Telmisartan: Telmisartan works by blocking the action of angiotensin II, a substance that constricts blood vessels. By inhibiting angiotensin II, telmisartan dilates blood vessels, reducing blood pressure.
• Hydrochlorothiazide: Hydrochlorothiazide promotes diuresis by enhancing the excretion of sodium and water from the body. This results in decreased blood volume, leading to reduced blood pressure.

Uses:

CO_TASMI 40MG TABLET is indicated for the treatment of hypertension in individuals who require combined therapy with telmisartan and hydrochlorothiazide for optimal blood pressure control. It is prescribed when monotherapy with either component is insufficient to achieve the desired blood pressure reduction.

Dosage and Administration:

The dosage of CO_TASMI 40MG TABLET is determined based on individual patient factors such as the severity of hypertension and response to treatment. It is typically administered orally once daily, with or without food. The tablet should be swallowed whole with a glass of water, without crushing or chewing.

Side Effects:

Common side effects associated with CO_TASMI 40MG TABLET may include:

• Dizziness
• Headache
• Fatigue
• Hypotension (low blood pressure)
• Electrolyte imbalances (e.g., low potassium levels)
• Increased uric acid levels
• Elevated blood glucose levels (especially in diabetic patients)
• Skin rash or allergic reactions

Precautions:

• Use CO_TASMI 40MG TABLET cautiously in patients with renal impairment, as it may exacerbate kidney dysfunction.
• Regular monitoring of electrolyte levels, particularly potassium, is advisable while on this medication.
• Patients should be cautious regarding activities requiring mental alertness, as dizziness or drowsiness may occur.
• Individuals with a history of gout should be monitored closely, as hydrochlorothiazide can exacerbate gout symptoms.

Conclusion:

CO_TASMI 40MG TABLET, containing telmisartan and hydrochlorothiazide, is prescribed for the management of hypertension. By blocking angiotensin II receptors and promoting diuresis, this combination medication effectively lowers blood pressure. However, it is crucial to use this medication under medical supervision to mitigate potential side effects and achieve optimal blood pressure control.